Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,596 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

NCT01286987

Conditions
Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
Locations
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
  • (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 15 locations
View Trial Details
Completed

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

NCT00087126

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Kaiser Permanente Medical Center - Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Olive View - UCLA Medical Center Foundation Sylmar, California, United States
View all 27 locations
View Trial Details
Completed

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

NCT01743469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Gastric Carcinoma, +38 more
Locations
  • Antwerp University Hospital, Wilrijkstraat 10 Edegem, Belgium
  • Ghent University Hospital, 1K12 IE, De Pintelaan 185 Ghent, Belgium
  • Leuven cancer institute (LKI), Herestraat Leuven, Belgium
  • Juravinski Cancer Centre, 699 Concession St Hamilton, Ontario, Canada
View all 24 locations
View Trial Details
Completed

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT00309959

Conditions
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, +15 more
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Carle Clinic-Urbana Main Urbana, Illinois, United States
  • Iowa Methodist Medical Center Des Moines, Iowa, United States
View all 26 locations
View Trial Details
Completed

Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy

NCT01663753

Conditions
Cancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Service de Médecine Nucléaire, Institut de cancérologie de l'Ouest - Site Paul Papin Angers, France
  • Service Gynécologie Obstétrique, Hôpital Pellegrin, CHU Bordeaux Bordeaux, France
  • Service de Gynécologie, Hôpital Femme Mère Enfant, Hospices Civils de Lyon Bron, France
  • Service de Chirurgie Oncologique, Centre de Lutte Contre le Cancer Georges-François Leclerc Dijon, France
View all 24 locations
View Trial Details

Related conditions